6-KThe Wire
Alpha Tau Medical Ltd. files 6-K
Filed Feb 24, 2026 · 5mo ago · Accession 0001213900-26-019635
Plain English
Alpha Tau Medical Ltd. announced on February 24, 2026, that it received Japanese marketing approval for its Alpha DaRT® product for unresectable locally advanced or locally recurrent head and neck cancer. This announcement was made via a press release attached to the Form 6-K.
Filing details
- Company
- Alpha Tau Medical Ltd.
- Ticker
- DRTS
- CIK
- 1871321
- Form type
- 6-K
- Filing date
- Feb 24, 2026
- Report date
- Feb 24, 2026
- Document
- ea0278144-6k_alpha.htm
- Size
- 28 KB